Global Oncology Drugs Market Report By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Other Cancers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213665
April 2021
Report Formats:
The global demand for Oncology Drugs Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2021 - 2027. Whereas with regards to volume, the market was calculated XX Kilo Tons in 2020 and foreseen to touch XX Kilo Tons by 2027 with a CAGR of XX% during 2021-2027.
 
Oncology drugs refer to medications used for cancer treatment. A drug used in cancer treatment varies in structure and mechanism of action. It kills cancer cells, stops them from growing and spreading to other parts of the body, helps the body regain strength, and develop new healthy cells. It also treats symptoms that cancer causes, like pain. With advances in understanding cancer biology, better treatment options, including drugs, are being devised, leading to new products approval and launch.
 
Market Dynamics
 
The growing burden of cancer diseases drives the growth of the global oncology drugs market. According to the World Health Organization estimates, the worldwide cancer burden is assessed to have ascended to 18.1 million new cases, and 9.6 million passings in 2018. It is projected that by 2030 between 10 and 11 million cancers will be diagnosed each year in low- and middle-income countries. The expanding disease burden is because of a few elements, including the aging population, changing lifestyle, among others. The growing approval for new drugs by the FDA and rising penetration of health insurance is amplifying revenue growth. Malignant of the lung, female breast, and colorectum are the top three cancers in terms of incidence, estimated to hold the majority share in global terms. However, expensive treatment and limited treatment options restrain the growth of the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of oncology drugs.
 
Market Segmentation
 
The entire oncology drugs market has been sub-categorized into drug class type and indication. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drug Class Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
 
By Indication
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for oncology drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Oncology Drugs Market Share by Region (Representative Graph)
 
Global Oncology Drugs Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oncology drugs market include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, f. Hoffmann-La Roche ltd., Johnson & Johnson (Janssen Global Services, LLC), Merck & Co., Inc., Novartis AG, Pfizer Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Oncology Drugs Market
       2.2. Global Oncology Drugs Market Snapshot
 
3 . ONCOLOGY DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Oncology Drugs Market
       3.3. Market Restraints of Oncology Drugs Market
       3.4. Opportunities of Oncology Drugs Market
       3.5. Trends of Oncology Drugs Market
       3.6. Porter’s Five Force Analysis of Oncology Drugs Market
       3.7. Oncology Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class Type
           3.7.2 Market Attractive Analysis by Indication
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Oncology Drugs Value Chain Analysis
       4.2. Oncology Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Oncology Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Oncology Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Oncology Drugs Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Oncology Drugs Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Oncology Drugs Market
       5.5. COVID-19: Micro and Macro Factor Analysis on Oncology Drugs Market
 
6 . GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY DRUG CLASS TYPE
       6.1 Overview by Drug Class Type
       6.2 Historical Data 2016-2019
       6.3 Global Oncology Drugs Market Analysis by Drug Class Type
       6.4 Market Analysis of Chemotherapy by Regions
       6.6 Market Analysis of Targeted Therapy by Regions
       6.5 Market Analysis of Immunotherapy (Biologic Therapy) by Regions
       6.7 Market Analysis of Hormonal Therapy by Regions
 
7 . GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical Data 2016-2019
       7.3 Global Oncology Drugs Market Analysis by Indication
       7.4 Market Analysis of Lung Cancer by Regions
       7.5 Market Analysis of Stomach Cancer by Regions
       7.6 Market Analysis of Colorectal Cancer by Regions
       7.7 Market Analysis of Breast Cancer by Regions
       7.8 Market Analysis of Prostate Cancer by Regions
       7.9 Market Analysis of Liver Cancer by Regions
       7.10. Market Analysis of Esophagus Cancer by Regions
       7.11 Market Analysis of Cervical Cancer by Regions
       7.12 Market Analysis of Kidney Cancer by Regions
       7.13 Market Analysis of Bladder Cancer by Regions
       7.14 Market Analysis of Other Cancers by Regions
 
8 . GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Oncology Drugs Market Estimate By Market Segment
           8.3.3. North America Oncology Drugs Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Oncology Drugs Market Estimate by Market Segment
           8.4.3. Europe Oncology Drugs Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Oncology Drugs Market Estimate by Market Segment
           8.5.3. Asia Pacific Oncology Drugs Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Oncology Drugs Market Estimate by Market Segment
           8.6.3. Latin America Oncology Drugs Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Oncology Drugs Market Estimate by Market Segment
           8.7.3. Middle East & Africa Oncology Drugs Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE ONCOLOGY DRUGS COMPANIES
       9.1. Oncology Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ONCOLOGY DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. AbbVie Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Astellas Pharma Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. AstraZeneca PLC
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Bristol-Myers Squibb Company
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Celgene Corporation
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. f. Hoffmann-La Roche ltd.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Johnson & Johnson (Janssen Global Services, LLC,)
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Merck & Co., Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Novartis AG
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Pfizer Inc..
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Oncology Drugs Market Snapshot
  • Drivers of The Global Oncology Drugs Market Impact Analysis
  • Restraints of The Global Oncology Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Oncology Drugs Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Oncology Drugs Market
  • COVID-19: Micro and Macro Factor Analysis on Oncology Drugs Market
  • Global Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Historic Data 2016-2019
  • Global Oncology Drugs Market Analysis in Chemotherapy by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Targeted Therapy by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Immunotherapy (Biologic Therapy) by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Hormonal Therapy by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis by Indication (Kilo Tons & USD MN)
  • Historic Data 2016-2019
  • Global Oncology Drugs Market Analysis in Lung Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Stomach Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Colorectal Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Breast Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Prostate Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Liver Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market Analysis in Esophagus Cancer by Geography (Kilo Tons & USD MN)
  • Global Oncology Drugs Market by Geography (Kilo Tons & USD MN)
  • Historic Data 2016-2019
  • North America Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • North America Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • North America Oncology Drugs Market Estimate by Country (Kilo Tons & USD MN)
  • United State Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • United State Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Canada Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Canada Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Mexico Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Mexico Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Europe Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Europe Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Europe Oncology Drugs Market Estimate by Country (Kilo Tons & USD MN)
  • United Kingdom Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • United Kingdom Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • France Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • France Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Germany Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Germany Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Italy Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Italy Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Russia Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Russia Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Spain Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Spain Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Rest of Europe Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Rest of Europe Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Asia Pacific Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Asia Pacific Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Asia Pacific Oncology Drugs Market Estimate by Country (Kilo Tons & USD MN)
  • China Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • China Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Japan Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Japan Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • India Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • India Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • South Korea Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • South Korea Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Australia Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Australia Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Rest of Asia Pacific Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Rest of Asia Pacific Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Latin America Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Latin America Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Latin America Oncology Drugs Market Estimate by Country (Kilo Tons & USD MN)
  • Brazil Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Brazil Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Argentina Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Argentina Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Peru Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Peru Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Chile Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Chile Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Rest of Latin America Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Rest of Latin America Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Middle East & Africa Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Middle East & Africa Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Middle East & Africa Oncology Drugs Market Estimate by Country (Kilo Tons & USD MN)
  • Saudi Arabia Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Saudi Arabia Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • UAE Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • UAE Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Israel Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Israel Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • South Africa Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • South Africa Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Rest of Middle East and Africa Oncology Drugs Market Analysis by Drug Class Type (Kilo Tons & USD MN)
  • Rest of Middle East and Africa Oncology Drugs Market Estimate by Indication (Kilo Tons & USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Oncology Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Oncology Drugs Market Size, by Region
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Class Type
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Oncology Drugs Market Analysis by Drug Class Type
  • Global Oncology Drugs Market Analysis in Chemotherapy by Region
  • Global Oncology Drugs Market Analysis in Targeted Therapy by Region
  • Global Oncology Drugs Market Analysis in Immunotherapy (Biologic Therapy) by Region
  • Global Oncology Drugs Market Analysis in Hormonal Therapy by Region
  • Global Oncology Drugs Market Analysis by Indication
  • Global Oncology Drugs Market Analysis in Lung Cancer by Region
  • Global Oncology Drugs Market Analysis in Stomach Cancer by Region
  • Global Oncology Drugs Market Analysis in Colorectal Cancer by Region
  • Global Oncology Drugs Market Analysis in Breast Cancer by Region
  • Global Oncology Drugs Market Analysis in Prostate Cancer by Region
  • Global Oncology Drugs Market Analysis in Liver Cancer by Region
  • Global Oncology Drugs Market Analysis in Esophagus Cancer by Region
  • Global Oncology Drugs Market by Volume And Revenue
  • North America Oncology Drugs Market by Volume And Revenue
  • Europe Oncology Drugs Market by Volume And Revenue
  • Asia Pacific Oncology Drugs Market by Volume And Revenue
  • Latin America Oncology Drugs Market by Volume And Revenue
  • Middle East & Africa Oncology Drugs Market by Volume And Revenue
  • Recent Development in Oncology Drugs Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials